is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Gregor founded Pharmacentric Solutions Ltd in 2017 to deliver consultancy services for the Pharma Industry specialising in device and packaging development and strategies from early concept through to commercial supply. Prior to this Gregor was Senior Design Director at GSK working as a device and packaging specialist and has over 30 years’ experience in Pharma and Medical Device design and is a named inventor on over 40 patents and has presented widely on topics such as Digital, Patient Centric Design and Pharma road mapping. He has a B.Sc. in Industrial Design and a M.Sc. in Polymer Science and Engineering. After 3 years at Smiths Medical Systems he joined the Device Development Unit at GSK R&D. He led platform developments including injectable and respiratory devices. In 2009 Greg moved to GSK Manufacturing as Global Head of Technical Packaging. In 2017 he authored the Technology and Innovation road map for UK Pharma.
Pfizer R&D UK Ltd | Senior Director, Head of the Devices Centre of Excellence
Nic Bowman is Senior Director, Head of the Devices Centre of Excellence (DCoE), Pfizer R&D UK Ltd, based in Cambridge UK. He has a BSc in Mechanical Engineering from Bath University, England (1984).Nic joined Pfizer in 2008. As Head of DCoE he has responsibility to deliver device solutions for a range of combination products, covering a wide variety of delivery routes.Nic is a Fellow of the Institution of Mechanical Engineers (FIMechE). He is a recognised expert in the field of device design, a regular conference speaker, and is named in over 20 patents.
Sanofi | Technology, Innovation, Process & Solution Head, Clinical Supplies R&D
Merck Healthcare | Global Head of
Connected Health & Medical Devices
David Braun is Global Head
of Medical Device Business Solution for Merck Healthcare. David is an executive leader that has 20 years of experience in research and development, operations, strategy and business management working in Europe, USA and Asia, in startups and large multinational companies. Through his career David gained significant experience designing winning organizations, leading and coaching cross functional teams bringing innovative products from ideation to launch. David is actually a Board director of Cellect, a biotech startup active in the field of
stem cells and medical devices.
Before joining Merck, David
served as Head of Operations and Global R&D of the Technology Business unit at Newell Brands, a Fortune 500 company, where he led key growth initiatives and multimillion dollar projects.
Prior to that, he worked as Vice President of R&D and Operations at Biosafe SA a medical device company recently acquired by GE, developing and launching products in the field of stem cell banking and cellular therapies. Previously,David also held various senior management and engineering roles in the aerospace and high tech industry.
David holds a Master degree
in applied physics from the Louis Pasteur University and a Degree in
Electro-Optical Engineering from the Jerusalem College of Technology. He has participated in Executive leadership and general management programs at the
Harvard Business School and IMD.
Boehringer Ingelheim Vetmedica GmbH | Head of Risk Management Sciences, Compliance and Quality
Martin Folger is currently (since September 2018) Head of Risk Management Sciences, Compliance and Quality within the global function Pharmaceutical Sciences at Boehringer Ingelheim Vetmedica GmbH. He is a pharmacist and holds a PhD in Pharmaceutical Technology from the Technical University of Braunschweig, Germany. After starting his career working in pharmaceutical manufacturing of oral solid dosage forms for two years for a major US-based pharmaceutical company, he joined the Animal Health business of Boehringer Ingelheim in 1997 as a manager in formulation development. From 2002 until September 2018 he was Head of Global CMC Development Pharmaceuticals and responsible for all CMC-related activities including e.g. packaging development. He currently also has the role as the Qualified Person for investigational veterinary product.
Auvergne University Faculty of Pharmacy Clermont-Ferrand, France | Pharmacist, PhD
Dr Pascale Gauthier is Pharmacist (D.Pharm) with background research (Masters in Biopharmaceutical, a specific Master (DEA) in Pharmacokinetics and a PhD in Pharmaceutical Technology) from Auvergne University. Charged of courses and involved in several patents,
international publications and conferences, her researches focused on modified release forms, pharmaceutical design & categories of users, digital in
health area as well as innovative packaging and formulations in cosmetic world.
Amgen | Director, Advanced Device Technology and Innovation & Device Technologies Innovation Center
Ferring Pharmaceuticals | Director of Procurement, Global Product Supply
Daniele has over 10 years’ experience of purchasing in Global Pharmaceutical Manufacturing and Supply Chain environments. He has held roles with increasing responsibility in multiple locations across Europe. At Abbott Laboratories, he enhanced his procurement expertise and pharmaceutical knowledge while based at a manufacturing plant in Italy, in the divisional offices in London & Dublin and also in the headquarters in Basel.
Daniele joined Ferring HQ near Lausanne (CH) in October 2013 as Global Category Manager, in charge of the global purchasing strategy and its execution for key packaging materials and medical devices used in Ferring Finished Products.
Daniele was appointed Head of Purchasing, Solids and Packaging Cluster in February 2017 and Director of Product Supply Direct Procurement in November 2017.
Daniele has a Masters Degree in Industrial Engineering from the University of Rome, Italy, followed by an MBA at the UCD Michael Smurfit Graduate Business School, Dublin, Ireland.
Novartis Pharma AG
Group Head Oral Packaging & Delivery Systems
Lionel Jeannin is an Arts & Métiers ParisTech Engineer with a Master degree in Business Administration from IAE Aix-Marseille Graduate School of Management.
He earned certificates in Biochemistry and Biology respectively from Harvard University and the Massachusetts Institute of Technology.He has more than 22 years’ experience in the Medical Device and Pharmaceutical industry and has worked as a Project and Development Team Manager in the Industrial Engineering, Ophthalmic surgery Medical Devices, Parenteral Nutrition and OTC/Rx Pharmaceutical development domains.He is currently heading the Oral Packaging and Delivery Systems Group in the Global Device and Packaging Development department of Novartis Pharma Technical Research and Development division.
Merck | Associate Director, Head of Sourcing Glass & Healthcare Innovation
Head of Technical and Pharmaceutical Operations
Dr Joël Richard is currently Head of Technical & Pharmaceutical Operations at MedinCell (Montpellier, France). He is leading all the pharmaceutical development and non-clinical pharmaco/toxico-kinetic activities of the company, specialized in the development of Long-Acting Injectables.(LAIs), using the proprietary technology BEPO®. Dr Richard has 30 years of experience in chemistry and biopharmaceutical R&D, including several global senior positions in various Biotech and Pharma companies, such as: -Senior Vice President, Pharmaceutical Development –Peptides in Ipsen (France), -Vice President, Drug Product Development in Ipsen (France), -Director, Pharmaceutical Development in Serono and Merck Serono (Italy, Germany), -Vice President Research, and Europe R&D Director at Ethypharm (France), -COO at Mainelab (France), a drug delivery company he co-founded, which was specialized in developing solvent-free processes for protein delivery systems. Since 1996, Dr Richard has focused his research activity on new formulation technologies and drug delivery systems (such as microspheres, nano systems, gelling systems, chemically-modified proteins, supercritical fluid technology . . .), especially for injectable peptide and protein formulations. Dr Richard has graduated from Ecole Normale Supérieure (Cachan, France). He has got a PhD in Materials Science from University of Paris, France, and the “Habilitation à Diriger les Recherches” degree in Chemistry from University of Bordeaux I. He has published 68 peer-reviewed scientific papers, 8 book chapters and 2 review editorials in various fields (colloids and interfaces, drug delivery systems, supercritical fluids, protein formulations, nanoparticles,…). He is the author of more than 140 international communications and 55patent families.
NOVARTIS AG | Head New Technologies, Device Development and Commercialisation
Marc holds a Master's degree in English and Biology from the Ruhr University in Bochum (Germany) and a Ph.D. in Pharmaceutical Technology from Heinrich Heine University in Düsseldorf (Germany).
He started his career in the pharmaceutical industry in 2001 in Germany, as Project Manager in Regulatory Affairs for Respimat® Soft Mist Inhaler at STEAG microParts GmbH. From 2004 to 2011, Marc held increasingly senior positions in the development of inhalation devices and formulations at Boehringer Ingelheim. In 2012, he joined the Biopharma division of Boehringer Ingelheim as Senior Manager, Technology and Innovation, before being appointed Head of Device Development and Combined Products for biopharmaceuticals in 2014. In July 2017, Marc joined Novartis Pharma AG as Head of New Technology, Device Development and Marketing within TRD.
Virbac | Head of Primary Packaging
Development, Corporate Pharma R&D Department
Packaging Engineer graduated from former-ESIEC (now ESIREIMS), Packing and Packaging Engineer School from Reims, Arnaud Steiner evolves in this world of packaging since his beginnings. After 5 years in the pharmaceutical industry for human health at AstraZeneca, on sites
of Reims and Dunkerque, he continued for 10 years in the food industry at Hochland near Verdun. Since 3 years, he is now in the pharmaceutical industry for animal health at Virbac, the 6th veterinary company worldwide, where he is head of primary packaging development in the Corporate pharma R&D department.
Head of Pharmaceutical Development Biologicals
AP-HP & ANSM Expert | Hospital Pharmacist
and President of the Pharmapack Jury
Philippe Arnaud is a pharmacist, Professor of the University, in the field of Pharmaceutical Sciences at the Faculty of Pharmacy of Paris and a Hospital Practitioner at the Public Assistance Hospitals of Paris.
He also taught during 10 years at the Faculty of Pharmacy of Rouen, and was a visiting Professor at University Laval, Quebec, Canada. He has been for more than 25 years an expert at the French Health National Agency ANSM for the pharmaceutical part of the AMM both in the field of originators, generics, allergenic products and biotechnology and was at the birth of Pharmapack and chaired the price jury. It accompanies the pharmaceutical development of a drug or a medical device and its packaging. He was for 10 years president of a trade union of hospital pharmacists the SNPHPU. He is member of the French National Academy of Pharmacy.
He is the author of more than 200 publications and communications in the field of pharmaceutical sciences as well as hospital pharmacy activity and market access.
Robert Debré Hospital, AP-HP, Paris Descartes | Chief of Pharmacy Department
Pharmaceutical Affairs Director
As a pharmacist and after two previous professional experiences : the first in a pharmaceutical firm and the second in the French Authorities, I have almost 20 years of experience in the Leem in the field of pharmaceutical quality. As Pharmaceutical Affairs Director, I have the leadership for responding to enquiries and needs in various domains as quality regulation, bioproduction and biodevelopment regulation, management of the pharmaceutical sites and activities of the responsible pharmacist and thus to fulfil the role of interlocutor between the Pharmaceutical Industry and the National Authorities, and particularly with the inspection of ANSM (the French Medicines Agency) or with the Health Ministery. Otherwise I work every day with sister-Associations.
The Leem is the French pharmaceutical Industry Association and federates more than 95 per cent of companies in France. Its main role is to act as a coordinator between its members to better influence the pharmaceutical environment, in its large expertise field: scientific, legal, economic, industrial, training, communication.
Eastern Parisian Hospital Group
Director of the Medication Department
Graduating as a pharmacist in 1989, Isabelle Debrix oriented her career towards hospital pharmacy. She was appointed Hospital Practitioner in 1995 at Hospital Tenon where she then served as the Pharmacy Department Head from 2009 to 2014. Presently Dr. Debrix manages the Medication Department for the Eastern Parisian Hospital Group including hospitals Saint Antoine, Tenon, Trousseau, Rothschild and Laroche Guyon.
Earning her PhD in 1994, Dr. Debrix pursued studies in medical and biological ethics and focused her research on the medical guidelines and proper use of oncological medicines. Part of this work was the subject of her 2002 post doctoral dissertation. She is the author or co-author of 24 international publications.
Dr. Debrix continues to engage in research and encourages the involvement of her team to evaluate professional pharmacy practices and develop innovative methods.
Her current research topics focus particularly on securing the delivery of medication to patients.
University of LILLE - France | Pharmacist, co-charge of the Pharmaceutical Industry Laboratory
Pr Anne Gayot, Pharmacist, co-charge of the Pharmaceutical Industry Laboratory at the University of LILLE-France, member of the French Pharmaceutical and Generic working group of ANSM.
Professor Anne GAYOT is in co-charge of the Pharmaceutical Industry Laboratory at the University of LILLE-France.This laboratory, beyond its teaching activities in the field of the development and production of pharmaceutical products, studies the solid state properties and properties of the particulate solid of the raw materials used in the formulation of drugs.It studies the physical properties of excipients and active substances with respect to functionnality characteristics. Professor Anne GAYOT was until reorganisation of the french agency member of the French Marketing authorization committee She is now member of the French Pharmaceutical and Generic working group at the French Agency. She participates to the writing of the guideline on Pharmaceutical Development of Medicines for Paediatric Use. She is the chair of the Functionnality Group related characteristics of the European Pharmacopoeia.She prepared her phD at the University of Lille (1981). It concerns microcapsules of activated charcoal for renal patients.Her scientific work concerns chacterisation of solid particles, extrusion-spheronisation, powder for inhalation. She is in charge of the master in industrial pharmaceutics.
Delphine Pernot holds a degree in agricultural engineering from AgroParisTech and a Master's degree in engineering and environmental management from ISIGE Mines Paristech. She began her career at AirParif, monitoring air quality before joining Deloitte in 2010 as a Sustainable Development consultant. Seven years later, Delphine Pernot joined Adelphe, EPR scheme for packaging in France, which deals specifically with pharmaceutical packaging. Her mission is to help clients in improving their packaging environmental footprint through building strong partnerships with stakeholders.
Société Française des Sciences et Techniques Pharmaceutiques | Vice President
Dr. Vincent BOUDY, Pharmacien, Ancien Interne des Hôpitaux de Paris, MCU-PH.
Directeur du Département Médico-Universitaire de l’Etablissement Pharmaceutique des Hôpitaux de Paris (AGEPS - APHP)) et Pharmacien Responsable Intérimaire.
Enseignant chercheur dans l’Unité de Technologies Chimiques et Biologiques pour la Santé (Université de Paris) rattaché à l’équipe Vecteurs pour l’Imagerie moléculaire et le Ciblage Thérapeutique de l’unité CNRS UMR8258 - Inserm U1022 de la Faculté de Pharmacie de PARIS.
Auteur de plus de 90 publications internationales et/nationales dont 10 brevets ou dépôt de demandes de brevet.
Vice-Président de la Société Française des Sciences et Techniques Pharmaceutiques.
Expert dans la sécurisation de la logistique sous température maîtrisée des produits de Santé.
Peylina Chu is a chemical engineer with over 25 years of experience in the EHS, sustainability and management consulting business. Her expertise includes stakeholder engagement and facilitation, strategic planning and risk management, and development of customized global programs. She has worked in a wide variety of industries, including technology, medical devices, healthcare, specialty chemical, pharmaceutical, food, and heavy manufacturing and works closely with global, regional, and local private clients. Peylina is Executive Director for the Healthcare Plastics Recycling Council (www.hprc.org), a private technical coalition of leading companies representing stakeholders across the healthcare plastics value chain. She is a Registered Professional Engineer and Vice President at Antea Group, and serves as Chair of the Board of Directors for the Inogen Environmental Alliance (www.inogenet.com), an alliance of global EHS and sustainability consultants.